42 completed, 7 terminated, 5 unknown, 2 withdrawn. 19 Phase 3, 19 Phase 4, 10 Phase 2, 5 Phase 1, 1 Not applicable.
Follow rasagiline: new trials by email Literature Review of rasagiline trials Research Report on rasagiline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relative Bioavailability Study of HNC364 Injectable Suspension HNC364 Injectable Suspension, Rasagiline Tablets - Parkinson's Disease (PD) | Phase 1 | Active not recruiting | Guangzhou Henovcom Bioscience Co. Ltd. | 30 | 2026-05-08 | 2026-06-02 |
| Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease Rasagiline - REM Sleep Behavior Disorder, Parkinson Disease | Phase 2 / Phase 3 | Withdrawn | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-01-01 | 2025-01-07 | |
| Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety" Rasagiline - Parkinson's Disease | Completed | Takeda | 1021 | 2018-11-01 | 2024-03-08 | |
| A Phase 3 Study With P2B001 in Subjects With Early Parkinson's P2B001 0.6/0.75 mg, Rasagiline 0.75 mg, Pramipexole 0.6 mg - Parkinson Disease, Early Parkinson's Disease | Phase 3 | Completed | Pharma Two B Ltd. | 544 | 2018-01-19 | 2023-03-21 |
| Image Parkinson's Disease Progression Study Rasagiline, Placebo, Magnetic Resonance Imaging - Parkinson's Disease | Phase 2 | Completed | University of Florida | 96 | 2016-12-01 | 2023-09-06 |
| Rasagiline Rescue in Alzheimer's Disease Clinical Trial Rasagiline, Placebo - Alzheimer's Disease | Phase 2 | Completed | The Cleveland Clinic | 50 | 2015-05-01 | 2020-11-10 |
| Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease. Rasagiline - Parkinson's Disease | Completed | State University of New York at Buffalo | 45 | 2014-11-01 | 2023-02-14 | |
| Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography computerized dynamic posturography, Rasagiline 1 mg capsule, Placebo - PARKINSON DISEASE (Disorder) | Phase 4 | Withdrawn | New York Medical College | 2014-09-15 | 2025-07-24 | |
| Azilect® In Wearing-Off (AIWO) Azilect® - Parkinson's Disease | Completed | Teva Pharma GmbH | 261 | 2014-01-01 | 2023-04-12 | |
| Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),, Placebo, P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), - Parkinson's Disease | Phase 2 / Phase 3 | Completed | Pharma Two B Ltd. | 149 | 2013-12-01 | 2023-04-07 |
| Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) Rasagiline, Placebo - Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Completed | Richard Barohn, MD | 80 | 2013-11-21 | 2020-01-27 |
| Ambulosono Rasagiline Musical Walking Study Azilect, Exercise, Music - Parkinson's Disease | Not applicable | Unknown | University of British Columbia | 60 | 2013-10-01 | 2015-04-02 |
| Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis Rasagiline, Placebo - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | University of Ulm | 252 | 2013-06-01 | 2016-10-25 |
| Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study AZILECT®, Placebo - Drug-naïve Patients With Parkinson's Disease, Apathy | Phase 4 | Unknown | University Hospital, Clermont-Ferrand | 50 | 2013-06-01 | 2013-01-10 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline Rasagiline, Placebo - Parkinson's Disease | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 64 | 2013-06-01 | 2013-12-20 |
| Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease Rasagiline, Placebo - Parkinson's Disease | Phase 4 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 170 | 2012-11-01 | 2021-11-09 |
| Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women Rasagiline - Parkinson's Disease | Phase 1 | Completed | H. Lundbeck A/S | 12 | 2012-05-01 | 2012-07-30 |
| Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China rasagiline, placebo - Parkinson's Disease | Phase 3 | Completed | H. Lundbeck A/S | 130 | 2012-04-01 | 2014-12-23 |
| A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy Rasagiline/Placebo, Rasagiline - Parkinson's Disease | Phase 4 | Completed | Georgetown University | 34 | 2012-01-01 | 2015-12-16 |
| Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China Placebo, Azilect® - Parkinson's Disease | Phase 3 | Completed | H. Lundbeck A/S | 321 | 2011-12-01 | 2018-09-10 |
Showing 20 of 57. Sign in to see all of them.
Parkinson Disease (45) · Amyotrophic Lateral Sclerosis (3) · Alzheimer Disease (2) · Anosmia (2) · Lethargy (2) · Cognitive Dysfunction (1) · Dementia (1) · Depression (1) · Fatigue (1) · Multiple System Atrophy (1) · Parasomnias (1) · REM Sleep Behavior Disorder (1) · Restless Legs Syndrome (1) · Retinal Detachment (1) · Schizophrenia (1)
Teva Branded Pharmaceutical Products R&D, Inc. (13) · H. Lundbeck A/S (4) · Merck Sharp & Dohme LLC (3) · Teva Neuroscience, Inc. (3) · Bial - Portela C S.A. (2) · Pharma Two B Ltd. (2) · Technische Universität Dresden (2) · University of Florida (2) · Brown University (1) · Chongqing Fortune Pharmaceutical Co., Ltd. (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Georgetown University (1) · Guangzhou Henovcom Bioscience Co. Ltd. (1) · Insel Gruppe AG, University Hospital Bern (1) · Istanbul University (1)
United States (23) · Germany (9) · Canada (7) · France (5) · China (4) · Spain (4) · Israel (3) · Italy (3) · Hungary (2) · Netherlands (2) · Portugal (2) · Switzerland (2) · United Kingdom (2) · Argentina (1) · Australia (1)
Phyllis Salzman, Ph.D. (4) · Albert C. Ludolph, MD, Prof. (1) · Alexander Storch, MD (1) · Andreas Ebneter (1) · Azhar Choudhry, M.D. (1) · Baorong Zhang, MD (1) · Bernad Ravina, MD. MSCE (1) · C Warren Olanow, MD, FRCPC (1) · Christian Baumann, Assoc Prof, MD (1) · David E Vaillancourt, PhD. (1)
PMID 19776408, PMID 21482191, PMID 25368372, PMID 25420207, PMID 25498732, PMID 26523919, PMID 27190009, PMID 28490648, PMID 29934198, PMID 29988514, PMID 30534374, PMID 37975796, PMID 38124528, PMID 42414790
2009 (6), 2008 (2), R01NS052318 (1)